Interesting that the trial was recruited between 2014 and 2016, ran for 12 months, with results not published until 2020.
- Forums
- ASX - By Stock
- DXB
- General Discussion
General Discussion, page-40
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
49.5¢ |
Change
0.020(4.21%) |
Mkt cap ! $261.3M |
Open | High | Low | Value | Volume |
47.5¢ | 50.0¢ | 47.5¢ | $404.7K | 831.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5854 | 49.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 195570 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5854 | 0.495 |
8 | 107771 | 0.490 |
6 | 334600 | 0.485 |
10 | 174987 | 0.480 |
8 | 164155 | 0.475 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 195570 | 8 |
0.505 | 119000 | 2 |
0.510 | 240806 | 6 |
0.515 | 101650 | 2 |
0.520 | 97859 | 5 |
Last trade - 10.34am 16/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online